Posttransplant Epstein-Barr virus related lymphoproliferative disorder with a primary cutaneous presentation

Dermatology Online Journal

Volumn 13, Issue 4, 2007, Pages

  Snavely, Nicholas R ^a   Sonabend, Michael ^a   Rosen, Ted ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; COTRIMOXAZOLE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; VALGANCICLOVIR; DRUG DERIVATIVE; MYCOPHENOLIC ACID;

ADULT; ARTICLE; BIOPSY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; LUNG FIBROSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; PHYSICAL EXAMINATION; POSTOPERATIVE INFECTION; SKIN MANIFESTATION; DOSE RESPONSE; FACE; LUNG TRANSPLANTATION; MIDDLE AGED; SKIN DISEASE; VIRUS INFECTION;

DOSE-RESPONSE RELATIONSHIP, DRUG; EPSTEIN-BARR VIRUS INFECTIONS; FACE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; PULMONARY FIBROSIS; SIROLIMUS; SKIN DISEASES;

EID: 36448956021     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Harris NL, Swerdlow SH, Frizzera G, Knowles DM. Posttransplant lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France; IARC Press; 2001. Pages 264-269.
2. Ploysangam T, Breneman D, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol 1998;38; 877-92.
3. Andreone P., Gramenzi A, Lorenzini S, Biselli M, Cursaro C, Pileri S, Bernardi M. Posttransplantation lymphoproliferative disorders. Arch Intern Med 2003; 163:1997-2004
4. Capaldi L, Robinson-Bostom L, Kerr P, Gohh R. Localized cutaneous posttransplant Epstein-Barr virus-associated lymphoproliferative disorder. J Am Acad Dermatol 2004;51:778-80.
5. Gonthier DM, Hartman G, Holley JL. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion. Am J Kidney Dis 1992;19; 600-03.
6. Chai C, White WL, Shea CR, Prieto VG. Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin. J Cutan Path 1999: 26:242-47.
7. Schumann KW, Oriba HA, Bergfeld WF, Hsi ED, Hollandsworth K. Cutaneous presentation of posttransplant lymphoproliferative disorder. J Am Acad Dermatol 2000; 42; 923-26.
8. Ahmed I, McEvoy MT. Cutaneous B-cell post transplant lymphoproliferative disorder: report of 7 cases. J Cutan Pathol 2000; 27:547. (Abstract only)
9. Blokx W, Andriesesen M, van Hammersvelt HW, van Krieken JH. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient. Case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease. Am J Dermatopathol 2002;24; 414-22.
10. Weeden D. Skin Pathology. London; Churchill Livingstone, 1997. Pages 216-230 and 897-921.
11. Kahn A, Horenstein M. Inflammatory Dermatopathology. The diagnosis of cutaneous inflammatory infiltrates with atypical CD30-positive cells. Pathol Case Rev 2004;9; 60-5.
12. Rijlaarsdam JU, Willemze R. Cutaneous pseudolymphomas: classification and differential diagnosis. Semin Dermatol 1994;13;187-96.
13. Cohen, JI. Epstein-Barr virus infection. N Engl J Med 2000;343; 481-492.
14. Ikediobi NI, Tyring SK. Cutaneous manifestations of Epstein-Barr virus infection. Dermatol Clin. 2002;20:283-9
15. Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dorken B, Riess H, Gartner B. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Ann Hematol 2006; 85; 478-84.
16. Jain AB, Marcos A, Pokharna R, Shapiro R, Fontes PA, Marsh W, Mohanka R, Fung JJ. Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation 2005;80; 1692-98.
17. Lorenzini S, Andreone P, Gramenzi A, Morelli C, Zinzani PL, Grazi GL, Pileri S, Baccarani M, Tura S, Bernardi M. Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases. Transplant Proc 2006;38; 1477-80.